Daniel Tasse - Net Worth and Insider Trading

Daniel Tasse Net Worth

The estimated net worth of Daniel Tasse is at least $11,557 dollars as of 2024-05-02. Daniel Tasse is the CHIEF EXECUTIVE OFFICER of DBV Technologies SA and owns about 17,094 shares of DBV Technologies SA (DBVT) stock worth over $11,557. Details can be seen in Daniel Tasse's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel Tasse has not made any transactions after 2024-03-08 and currently still holds the listed stock(s).

Transaction Summary of Daniel Tasse

To

Daniel Tasse Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Tasse owns 5 companies in total, including Regenxbio Inc (RGNX) , Bellerophon Therapeutics Inc (BLPH) , and Mallinckrodt PLC (MNKKQ) among others .

Click here to see the complete history of Daniel Tasse’s form 4 insider trades.

Insider Ownership Summary of Daniel Tasse

Ticker Comapny Transaction Date Type of Owner
RGNX Regenxbio Inc 2016-08-15 director
BLPH Bellerophon Therapeutics Inc 2015-02-13 director
MNKKQ Mallinckrodt PLC 2015-05-01 Interim Pres-Hospital Business
2024-03-08 director & Chief Executive Officer
2015-05-01 Interim Pres-Hospital Business

Daniel Tasse Latest Holdings Summary

Daniel Tasse currently owns a total of 1 stock. Daniel Tasse owns 17,094 shares of DBV Technologies SA (DBVT) as of March 8, 2024, with a value of $11,557.

Latest Holdings of Daniel Tasse

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DBVT DBV Technologies SA 2024-03-08 17,094 0.68 11,557

Holding Weightings of Daniel Tasse


Daniel Tasse Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Tasse has made a total of 1 transactions in DBV Technologies SA (DBVT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in DBV Technologies SA is the acquisition of 17,094 shares on March 8, 2024, which cost Daniel Tasse around $14,188.

Insider Trading History of Daniel Tasse

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Tasse Trading Performance

GuruFocus tracks the stock performance after each of Daniel Tasse's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Tasse is %. GuruFocus also compares Daniel Tasse's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Tasse within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daniel Tasse's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daniel Tasse

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.24
Relative Return to S&P 500(%) -11.78

Daniel Tasse Ownership Network

Ownership Network List of Daniel Tasse

No Data

Ownership Network Relation of Daniel Tasse


Daniel Tasse Owned Company Details

What does Regenxbio Inc do?

Who are the key executives at Regenxbio Inc?

Daniel Tasse is the director of Regenxbio Inc. Other key executives at Regenxbio Inc include director & See Remarks Kenneth T. Mills , Chief Medical Officer Steve Pakola , and See Remarks Vittal Vasista .

Regenxbio Inc (RGNX) Insider Trades Summary

Over the past 18 months, Daniel Tasse made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 135,000 shares made by Kenneth T. Mills , and a net sale of 12,878 shares made by Steve Pakola .

In summary, during the past 3 months, insiders sold 57,878 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 57,878 shares. During the past 18 months, 147,878 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 147,878 shares.

Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regenxbio Inc Insider Transactions

No Available Data

Daniel Tasse Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Tasse. You might contact Daniel Tasse via mailing address: C/o Ikaria, Inc., 6 State Route 173, Clinton Nj 08809.

Discussions on Daniel Tasse

No discussions yet.